Terrestrial

Biotechnology ResearchMassachusetts, United States51-200 Employees

Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1. 

Terrestrial’s proprietary microarray patch (MAP) and applicator platform consists of a patch resembling an adhesive bandage, which is applied with a preloaded applicator and removed after a few minutes. Once applied, each patch delivers bioactive tips into the skin, which dissolve quickly into the body, rapidly releasing their therapeutic payload. Designed for self-administration, the temperature-stable MAP platform enables precise, controlled delivery of a wide range of therapeutics without medical sharps or refrigeration. 

Terrestrial has generated strong clinical and in-vivo proof of concept across multiple molecules. For more information, visit www.terrestrialbio.com

Sign up for free to view info

Email Format Employee directory